Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Depression and violence—what do we really know?

Menkes DB, Herxheimer A.

Lancet Psychiatry. 2015 Jun;2(6):491-2. doi: 10.1016/S2215-0366(15)00166-2. Epub 2015 May 27. No abstract available.

PMID:
26360436
2.

Assessing alcohol problems: need for a thorough medication history.

Menkes DB, Herxheimer A.

BMJ. 2015 Mar 10;350:h1281. doi: 10.1136/bmj.h1281. No abstract available.

PMID:
25758380
3.

Including partners in trials of financial incentives for smoking cessation in pregnancy.

Herxheimer A.

BMJ. 2015 Feb 18;350:h854. doi: 10.1136/bmj.h854. No abstract available.

PMID:
25694112
4.

Interaction between antidepressants and alcohol: signal amplification by multiple case reports.

Menkes DB, Herxheimer A.

Int J Risk Saf Med. 2014;26(3):163-70. doi: 10.3233/JRS-140632.

PMID:
25214162
5.

Jet lag.

Herxheimer A.

BMJ Clin Evid. 2014 Apr 29;2014. pii: 2303. Review.

6.

Independent drug information in Burkina Faso is key to improving public health.

Tognoni G, Toussaint B, Herxheimer A, Schaaber J.

Lancet. 2014 Mar 1;383(9919):784. doi: 10.1016/S0140-6736(14)60404-9. No abstract available.

PMID:
24581667
7.

Department of Health's misguided alert recommending neuraminidase inhibitors for flu.

McGettigan P, Pollock A, Herxheimer A.

BMJ. 2014 Feb 19;348:g1594. doi: 10.1136/bmj.g1594. No abstract available.

PMID:
24554184
8.

Problems of polypharmacy.

Herxheimer A, McGettigan P.

BMJ. 2013 Dec 23;347:f7500. doi: 10.1136/bmj.f7500. No abstract available.

PMID:
24366533
9.

Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator® ) withdrawal in France.

Abou Taam M, Rossard C, Cantaloube L, Bouscaren N, Roche G, Pochard L, Montastruc F, Herxheimer A, Montastruc JL, Bagheri H.

J Clin Pharm Ther. 2014 Feb;39(1):53-5. doi: 10.1111/jcpt.12103. Epub 2013 Oct 21.

PMID:
24304185
10.

Please give more details in the Minerva case of nicorandil induced perianal ulceration.

Herxheimer A.

BMJ. 2013 Jul 16;347:f4353. doi: 10.1136/bmj.f4353. No abstract available.

PMID:
23861415
11.

Pharmacovigilance on the turn? Adverse reactions methods in 2012.

Herxheimer A.

Int J Risk Saf Med. 2013 Jan 1;25(1):29-31. doi: 10.3233/JRS-130583. No abstract available.

PMID:
23442295
12.

A major rethink is needed on reporting adverse drug reactions.

Herxheimer A, Vohra S, Montastruc JL, Edwards R.

BMJ. 2012 Sep 24;345:e6379. doi: 10.1136/bmj.e6379. No abstract available.

PMID:
23008204
13.

Pharmacovigilance on the turn? Adverse reactions methods in 2012.

Herxheimer A.

Br J Gen Pract. 2012 Aug;62(601):400-1. doi: 10.3399/bjgp12X653453. No abstract available.

14.

Marketing versus evidence-based medicine.

Braillon A, Bewley S, Herxheimer A, Mansfield P, Lexchin J, Menkes DB, Ziganshina LE, Montastruc JL.

Lancet. 2012 Jul 28;380(9839):340. doi: 10.1016/S0140-6736(12)61250-1. No abstract available.

PMID:
22841337
15.

Case histories as evidence.

Herxheimer A, Healy D, Menkes DB.

Int J Risk Saf Med. 2012;24(1):23-9. doi: 10.3233/JRS-2012-0549.

PMID:
22436256
16.

Public understanding of drug therapy.

Herxheimer A.

Br J Clin Pharmacol. 2012 Jun;73(6):943-7. doi: 10.1111/j.1365-2125.2012.04243.x.

17.

Quality information for quality use of medicines; 2nd International Conference, Kazan, 15-16 October 2010.

Ziganshina LE, Menkes DB, Herxheimer A.

Int J Risk Saf Med. 2011;23(3):187-92. doi: 10.3233/JRS-2011-0535.

PMID:
22020399
18.

Unexpected aggressive behaviour: interaction of bupropion and alcohol.

Chandler P, Herxheimer A.

Int J Risk Saf Med. 2011;23(3):133-7. doi: 10.3233/JRS-2011-0533. Erratum in: Int J Risk Saf Med. 2011;23(4):257.

PMID:
22020393
19.

Looking at EU pharmacovigilance.

Herxheimer A.

Eur J Clin Pharmacol. 2011 Nov;67(11):1201-2. doi: 10.1007/s00228-011-1074-8. Epub 2011 Jul 13. No abstract available.

PMID:
21750941
20.

[Patients reported adverse drug reactions: what's happening in Europe].

Herxheimer A, Crombag R, Alves TL.

Assist Inferm Ric. 2011 Jan-Mar;30(1):42-7. Italian.

PMID:
21539077
21.

Is there a need for forensic pharmacovigilance as a specialty?

Body D, Edwards IR, Hartigan Go K, Healy D, Herxheimer A, Labadie J.

Int J Risk Saf Med. 2011;23(1):31-42. doi: 10.3233/JRS-2011-0518. No abstract available.

PMID:
21507784
22.

Nurses should be encouraged and helped to monitor patients' medicines.

Herxheimer A, Ziebland S.

J Nurs Manag. 2011 Apr;19(3):393-4. doi: 10.1111/j.1365-2834.2011.01234.x. No abstract available.

PMID:
21507110
23.

A/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir.

Herxheimer A, Clarke M, Edwards R, Jefferson T, Loke Y.

BMJ. 2009 Jul 28;339:b3048. doi: 10.1136/bmj.b3048. No abstract available.

PMID:
19638383
24.

Oestrogens and progestins for preventing and treating postpartum depression.

Dennis CL, Ross LE, Herxheimer A.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD001690. doi: 10.1002/14651858.CD001690.pub2. Review.

PMID:
18843619
25.

How patients' experiences contribute to decision making: illustrations from DIPEx (personal experiences of health and illness).

Ziebland S, Herxheimer A.

J Nurs Manag. 2008 May;16(4):433-9. doi: 10.1111/j.1365-2834.2008.00863.x.

PMID:
18405260
26.

Medical justice for undocumented migrants.

Arnold F, Chalmers I, Herxheimer A, Lewith G, Kennedy S, Kandela P, Nicholl D, Campion D, Morton H, Natarajan R, Milne R, Chung E, Jobst KA, McCulloch P, Halpin D, Goldwyn C, Denman C, Hey E, Zajicek J, Fulton J, Alderson P, Williams H, Gilbert R, Baum M.

Lancet. 2008 Jan 19;371(9608):201. doi: 10.1016/S0140-6736(08)60110-5. No abstract available.

PMID:
18207009
27.

Social, cultural and ethical aspects of drug use -- changes over 40 years: a personal look back.

Herxheimer A, Sanz E.

Eur J Clin Pharmacol. 2008 Feb;64(2):107-14. doi: 10.1007/s00228-007-0429-7. Epub 2008 Jan 3. No abstract available.

PMID:
18172625
28.

Jet lag.

Herxheimer A.

BMJ Clin Evid. 2008 Dec 4;2008. pii: 2303. Review.

29.

Systematic reviews of adverse effects: framework for a structured approach.

Loke YK, Price D, Herxheimer A; Cochrane Adverse Effects Methods Group.

BMC Med Res Methodol. 2007 Jul 5;7:32. Review.

30.

What people close to death say about euthanasia and assisted suicide: a qualitative study.

Chapple A, Ziebland S, McPherson A, Herxheimer A.

J Med Ethics. 2006 Dec;32(12):706-10.

31.

Antidepressants and violence: problems at the interface of medicine and law.

Healy D, Herxheimer A, Menkes DB.

PLoS Med. 2006 Sep;3(9):e372. Review. No abstract available.

32.
33.

Does melatonin help people sleep?

Herxheimer A.

BMJ. 2006 Feb 18;332(7538):373-4. No abstract available.

34.

Guest editorial.

Herxheimer A.

Health Expect. 2005 Dec;8(4):283-5. No abstract available.

35.

Tamoxifen and the singing voice.

Herxheimer A.

PLoS Med. 2005 Sep;2(9):e310. Epub 2005 Sep 27. No abstract available.

36.

Jet lag.

Herxheimer A.

Clin Evid. 2005 Jun;(13):2178-83. Review. No abstract available.

PMID:
16135324
37.

Effectiveness of antimalarial drugs.

Croft AM, Beer MD, Herxheimer A.

N Engl J Med. 2005 Jul 28;353(4):420-2; author reply 420-2. No abstract available.

PMID:
16050052
38.

Jet lag.

Herxheimer A.

Clin Evid. 2004 Dec;(12):2394-400. Review. No abstract available. Update in: Clin Evid. 2005 Jun;(13):2178-83.

PMID:
15865798
39.

Many people with epilepsy want to know more: a qualitative study.

Prinjha S, Chapple A, Herxheimer A, McPherson A.

Fam Pract. 2005 Aug;22(4):435-41. Epub 2005 Apr 6.

PMID:
15814581
40.

Communicating with patients about harms and risks.

Herxheimer A.

PLoS Med. 2005 Feb;2(2):e42. Epub 2005 Feb 22. No abstract available.

41.

Jet lag.

Herxheimer A.

Clin Evid. 2004 Jun;(11):2243-8. Review. No abstract available. Update in: Clin Evid. 2004 Dec;(12):2394-400.

PMID:
15652110
42.

Open access to industry's clinically relevant data.

Herxheimer A.

BMJ. 2004 Jul 10;329(7457):64-5. No abstract available.

43.

Open letter to Annette King, Minister of Health, New Zealand.

Herxheimer A.

BMJ. 2004 Jul 3;329(7456):51. No abstract available.

44.

Depressing research.

Medawar C, Hardon A, Herxheimer A.

Lancet. 2004 Jun 19;363(9426):2087. No abstract available.

PMID:
15207964
46.

Antidepressants and adverse effects in young patients: uncovering the evidence.

Herxheimer A, Mintzes B.

CMAJ. 2004 Feb 17;170(4):487-9. No abstract available.

47.

Considering resistance in systematic reviews of antibiotic treatment.

Leibovici L, Soares-Weiser K, Paul M, Goldberg E, Herxheimer A, Garner P.

J Antimicrob Chemother. 2003 Oct;52(4):564-71. Epub 2003 Sep 1. Review.

PMID:
12951336
48.

Relationships between the pharmaceutical industry and patients' organisations.

Herxheimer A.

BMJ. 2003 May 31;326(7400):1208-10. No abstract available.

49.

DIPEx: fresh insights for medical practice.

Herxheimer A, Ziebland S.

J R Soc Med. 2003 May;96(5):209-10. No abstract available.

50.

[DIPEx (Database of Individual Patients Experience of illness): a multimedia proposal to share experiences and information about illnesses between patients and health professionals].

Herxheimer A, McPherson A, Miller R, Chapple A, Shepperd S, Ziebland S, Sanz E.

Aten Primaria. 2003;31(6):386-8. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center